secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0000950170-25-062913
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences amends merger with Roosevelt: extends deadline, revises share formula
--------------------------------------------------------------------------------

- Termination date extended from May 15, 2025 to August 15, 2025.
- Exchange shares fixed at 90% of post-closing outstanding (floor of 80%); prior cash adjustments removed.
- Eliminated definitions for Cash Amount, Surplus Amount, Deficit Amount, and Trading Price.
- Closing condition amended to require tax-free exchange under Section 351(a) of the Code.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017025062913/0000950170-25-062913-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017025062913/rkda-20250430.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-062913

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer